Healthcare provider profile · identity verified

James M Learner, DO

Internal Medicine · MILFORD, MI · NPI 1053422006

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	732	213
Amlodipine Besylate	Amlodipine Besylate	499	143
Levothyroxine Sodium	Levothyroxine Sodium	479	111
Losartan Potassium	Losartan Potassium	359	106
Montelukast Sodium	Montelukast Sodium	298	85
Lisinopril	Lisinopril	293	88
Pantoprazole Sodium	Pantoprazole Sodium	275	86
Metformin Hcl	Metformin Hcl	268	84
Gabapentin	Gabapentin	239	64
Rosuvastatin Calcium	Rosuvastatin Calcium	237	78
Omeprazole	Omeprazole	229	63
Tamsulosin Hcl	Tamsulosin Hcl	229	67
Simvastatin	Simvastatin	220	59
Alprazolam	Alprazolam	194	39
Metoprolol Succinate	Metoprolol Succinate	194	57
Hydrochlorothiazide	Hydrochlorothiazide	174	52
Tramadol Hcl	Tramadol Hcl	171	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	140	22
Pravastatin Sodium	Pravastatin Sodium	134	34
Furosemide	Furosemide	127	40
Trazodone Hcl	Trazodone Hcl	124	40
Albuterol Sulfate Hfa	Albuterol Sulfate	120	40
Metoprolol Tartrate	Metoprolol Tartrate	116	33
Zolpidem Tartrate	Zolpidem Tartrate	112	15
Escitalopram Oxalate	Escitalopram Oxalate	110	27
Meloxicam	Meloxicam	99	28
Ozempic	Semaglutide	99	20
Celecoxib	Celecoxib	98	27
Glimepiride	Glimepiride	97	30
Azithromycin	Azithromycin	93	63
Ezetimibe	Ezetimibe	89	29
Carvedilol	Carvedilol	88	30
Eliquis	Apixaban	88	28
Allopurinol	Allopurinol	86	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	84	17
Potassium Chloride	Potassium Chloride	78	27
Clopidogrel	Clopidogrel Bisulfate	77	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	20
Naproxen	Naproxen	76	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	24
Jardiance	Empagliflozin	72	25
Xarelto	Rivaroxaban	71	14
Finasteride	Finasteride	68	24
Sertraline Hcl	Sertraline Hcl	68	23
Fluticasone Propionate	Fluticasone Propionate	65	28
Bupropion Xl	Bupropion Hcl	64	17
Warfarin Sodium	Warfarin Sodium	63	13
Alendronate Sodium	Alendronate Sodium	61	19
Prednisone	Prednisone	60	39
Ibuprofen	Ibuprofen	59	23
Acetaminophen-Codeine	Acetaminophen With Codeine	58	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	17
Donepezil Hcl	Donepezil Hcl	55	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	15
Methylprednisolone	Methylprednisolone	50	34
Lorazepam	Lorazepam	49	16
Citalopram Hbr	Citalopram Hydrobromide	48	12
Atenolol	Atenolol	45	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	12
Famotidine	Famotidine	44	19
Lidocaine	Lidocaine	44	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	30
Clonazepam	Clonazepam	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	23
Fluoxetine Hcl	Fluoxetine Hcl	37	14
Pregabalin	Pregabalin	37	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	37	13
Duloxetine Hcl	Duloxetine Hcl	35	11
Entresto	Sacubitril/Valsartan	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Diazepam	Diazepam	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	11
Methocarbamol	Methocarbamol	33	suppressed
Spironolactone	Spironolactone	33	11
Valacyclovir	Valacyclovir Hcl	32	13
Paroxetine Hcl	Paroxetine Hcl	31	11
Bumetanide	Bumetanide	30	11
Buspirone Hcl	Buspirone Hcl	30	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Labetalol Hcl	Labetalol Hcl	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Ramipril	Ramipril	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Irbesartan	Irbesartan	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Dutasteride	Dutasteride	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	12
Hydrocortisone	Hydrocortisone	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	13
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Fluconazole	Fluconazole	22	14
Memantine Hcl	Memantine Hcl	22	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Tresiba Flextouch U-200	Insulin Degludec	22	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	20
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Temazepam	Temazepam	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Estradiol	Estradiol	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Tadalafil	Tadalafil	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lithium Carbonate Er	Lithium Carbonate	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Armour Thyroid	Thyroid,pork	14	suppressed
Baclofen	Baclofen	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Cephalexin	Cephalexin	12	11
Cilostazol	Cilostazol	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Alosetron Hcl	Alosetron Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Clarithromycin	Clarithromycin	11	11
Creon	Lipase/Protease/Amylase	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Glipizide	Glipizide	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error